Full Spectrum Hawthorn Extract
Product analysis
Full Spectrum Hawthorn Extract offers favorable serving-cost value while keeping hawthorn as its main appeal. Different hawthorn amount declarations make its total exposure unclear.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
A hawthorn constituent is identified, but preparation quality remains uncertain. The calcium form and carbohydrate type are also unspecified.
Ingredient Transparency75
The listed amounts are disclosed, but not all sources are named. Different hawthorn declarations should be clarified before comparing total exposure.
Value For Money88
The hawthorn serving offers favorable value. Calcium and carbohydrate contributions remain uncertain and do not explain an additional cost advantage.
Customer Satisfaction72
Buyer ratings are very positive. The modest number of ratings offers a narrower picture of satisfaction.
Product Focus72
Hawthorn is the main focus within a small ingredient combination. The intended uses have support, although a specific outcome cannot be inferred from the composition alone.
- Format
Tablet - Container
- 30 Tablet(s)
- Per serving
- $0.21
- Customer rating
- 4.7 · 145 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Total Carbohydrates | 1 Gram(s) | |
Calcium | 27 mg | |
Hawthorn leaf & flower extract (Vitexin) | 450 mg | |
Hawthorn | 100 mg |
How this ingredient is rated
Composition and Label Disclosure29
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability100
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.